Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia

被引：49

作者：

Helal, Christopher J. ^{[1
]}

Kang, Zhijun ^{[1
]}

Hou, Xinjun ^{[1
]}

Pandit, Jayvardhan ^{[1
]}

Chappie, Thomas A. ^{[1
]}

Humphrey, John M. ^{[1
]}

Marr, Eric S. ^{[1
]}

Fennell, Kimberly F. ^{[1
]}

Chenard, Lois K. ^{[1
]}

Fox, Carol ^{[1
]}

Schmidt, Christopher J. ^{[1
]}

Williams, Robert D. ^{[1
]}

Chapin, Douglas S. ^{[1
]}

Siuciak, Judith ^{[1
]}

Lebel, Lorraine ^{[1
]}

Menniti, Frank ^{[1
]}

Cianfrogna, Julia ^{[1
]}

Fonseca, Kari R. ^{[1
]}

Nelson, Frederick R. ^{[1
]}

O'Connor, Rebecca ^{[1
]}

MacDougall, Mary ^{[1
]}

McDowell, Laura ^{[1
]}

Liras, Spiros ^{[1
]}

机构：

[1] Pfizer Worldwide Res & Dev, Groton, CT 06340 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 13期

关键词：

CENTRAL-NERVOUS-SYSTEM; P-GLYCOPROTEIN; III INHIBITOR; DRUGS; GENERATION; PDE10A; LIGAND; BRAIN;

D O I：

10.1021/jm2001508

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Utilizing structure-based virtual library design and scoring, a novel chimeric series of phosphodiesterase 10A (PDE10A) inhibitors was discovered by synergizing binding site interactions and ADME properties of two chemotypes. Virtual libraries were docked and scored for potential binding ability, followed by visual inspection to prioritize analogs for parallel and directed synthesis. The process yielded highly potent and selective compounds such as 16. New X-ray cocrystal structures enabled rational design of substituents that resulted in the successful optimization of physical properties to produce in vivo activity and to modulate microsomal clearance and permeability.

引用

页码：4536 / 4547

页数：12

共 50 条

[1] Utilizing structure-based design to discover a potent, selective, in vivo active PDE10A inhibitor lead series for the treatment of schizophrenia
Hou, Xinjun
Helal, Christopher J.
Kang, Zhijun
Pandit, Jay
Marr, Eric
Fennell, Kimberly F.
Chenard, Lois
Fox, Carol
Schmidt, Christopher J.
Williams, Robert D.
Chapin, Douglas
Siuciak, Judy
Lebel, Lorraine
Menniti, Frank
Cianfrogna, Julia
Schmidt, Kari
Nelson, Fred
Liras, Spiros
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[2] Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia
Manuel Bartolome-Nebreda, Jose
Delgado, Francisca
Luz Martin-Martin, Maria
Martinez-Viturro, Carlos M.
Pastor, Joaquin
Min Tong, Han
Iturrino, Laura
Macdonald, Gregor J.
Sanderson, Wendy
Megens, Anton
Langlois, Xavier
Somers, Marijke
Vanhoof, Greet
Conde-Ceide, Susana
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 4196 - 4212
[3] Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Martin, Laetitia J.
Koegl, Manfred
Bader, Gerd
Cockcroft, Xiao-Ling
Fedorov, Oleg
Fiegen, Dennis
Gerstberger, Thomas
Hofmann, Marco H.
Hohmann, Anja F.
Kessler, Dirk
Knapp, Stefan
Knesl, Petr
Kornigg, Stefan
Muller, Susanne
Nar, Herbert
Rogers, Catherine
Rumpel, Klaus
Schaaf, Otmar
Steurer, Steffen
Tallan, Cynthia
Vakoc, Christopher R.
Zeeb, Markus
Zoephel, Andreas
Pearson, Mark
Boehmelt, Guido
McConnell, Darryl
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4462 - 4475
[4] Identification of dual inhibitor of phosphodiesterase 1B/10A using structure-based drug design approach
Al-Nema, Mayasah
Gaurav, Anand
Lee, Vannajan Sanghiran
Gunasekaran, Baskaran
Lee, Ming Tatt
Okechukwu, Patrick
JOURNAL OF MOLECULAR LIQUIDS, 2021, 342 (342)
[5] Addressing phototoxicity observed in a novel series of biaryl derivatives: Discovery of potent, selective and orally active phosphodiesterase 10A inhibitor ASP9436
Hamaguchi, Wataru
Masuda, Naoyuki
Miyamoto, Satoshi
Kikuchi, Shigetoshi
Narazaki, Fumie
Shiina, Yasuhiro
Seo, Ryushi
Amano, Yasushi
Mihara, Takuma
Moriguchi, Hiroyuki
Hattori, Kouji
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3351 - 3367
[6] Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Helal, Christopher J.
Arnold, Eric P.
Boyden, Tracey L.
Chang, Cheng
Chappie, Thomas A.
Fennell, Kimberly F.
Forman, Michael D.
Hajos, Mihaly
Harms, John F.
Hoffman, William E.
Humphrey, John M.
Kang, Zhijun
Kleiman, Robin J.
Kormos, Bethany L.
Lee, Che-Wah
Lu, Jiemin
Maklad, Noha
McDowell, Laura
Mente, Scot
O'Connor, Rebecca E.
Pandit, Jayvardhan
Piotrowski, Mary
Schmidt, Anne W.
Schmidt, Christopher J.
Ueno, Hirokazu
Verhoest, Patrick R.
Yang, Edward X.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5673 - 5698
[7] In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents
Suzuki, Kazunori
Harada, Akina
Shiraishi, Eri
Kimura, Haruhide
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (03): : 471 - 479
[8] Structure-based design of potent CDK4 selective inhibitor.
Honma, T
Hayashi, K
Kawanishi, N
Yoshizumi, T
Hashimoto, N
Sugimoto, T
Nakamura, K
Takaki, T
Machida, T
Fukasawa, K
Hirai, H
Iwama, T
Ikeura, C
Ikuta, M
Kamata, K
Suzuki-Takahashi, I
Hayama, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U24 - U24
[9] Structure-based design of a potent and selective peptide inhibitor of caspase-3
Yoshimori, A
Takasawa, R
Sakai, J
Kobayashi, T
Sunaga, S
Tanuma, SI
FEBS JOURNAL, 2005, 272 : 523 - 523
[10] Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
Shipe, William D.
Sharik, Steven S.
Barrow, James C.
McGaughey, Georgia B.
Theberge, Cory R.
Uslaner, Jason M.
Yan, Youwei
Renger, John J.
Smith, Sean M.
Coleman, Paul J.
Cox, Christopher D.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (19) : 7888 - 7894

← 1 2 3 4 5 →